- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
10
Companies which are potentially undervalued and in an acceptable financial position.
10 companies
High Tide
Market Cap: CA$279.3m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.11
7D
-5.5%
1Y
-26.5%
Verano Holdings
Market Cap: CA$610.3m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$1.68
7D
-0.6%
1Y
-1.2%
Aurora Cannabis
Market Cap: CA$289.8m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$4.52
7D
-20.3%
1Y
-49.6%
Curaleaf Holdings
Market Cap: CA$2.4b
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$2.98
7D
-1.0%
1Y
28.4%
Medexus Pharmaceuticals
Market Cap: CA$92.5m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.84
7D
-0.7%
1Y
-6.9%
Trulieve Cannabis
Market Cap: CA$1.8b
Operates as a cannabis retailer.
TRUL
CA$9.30
7D
-2.1%
1Y
37.2%
TerrAscend
Market Cap: CA$348.5m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.85
7D
0%
1Y
-15.8%
Cresco Labs
Market Cap: CA$665.3m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.38
7D
-2.1%
1Y
0.7%
Knight Therapeutics
Market Cap: CA$584.2m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$5.84
7D
0.7%
1Y
1.6%
Organigram Global
Market Cap: CA$287.6m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$2.03
7D
-4.7%
1Y
-14.7%